The ADAMTS13‐von Willebrand factor axis in COVID‐19 patients

Pulmonary Embolism in COVID-19 Patients: Awareness of an Increased Prevalence

(2020) Julien Poissy et al.   CIRCULATION

COVID-19 and Multiorgan Response

(2020) Sevim Zaim et al.   CURRENT PROBLEMS IN CARDIOLOGY

High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study

(2020) Julie Helms et al.   INTENSIVE CARE MEDICINE

Involvement of ADAMTS13 and von Willebrand factor in thromboembolic events in patients infected with SARS‐CoV‐2

(2020) Albert Huisman et al.   International Journal of Laboratory Hematology

Complement activation in patients with COVID-19: A novel therapeutic target

(2020) Massimo Cugno et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Hypercoagulability of COVID‐19 patients in Intensive Care Unit. A Report of Thromboelastography Findings and other Parameters of Hemostasis

(2020) Mauro Panigada et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

High incidence of venous thromboembolic events in anticoagulated severe COVID‐19 patients

(2020) Jean‐François Llitjos et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Incidence of venous thromboembolism in hospitalized patients with COVID‐19

(2020) Saskia Middeldorp et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia

(2020) Songping Cui et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Endothelial cell infection and endotheliitis in COVID-19

(2020) Zsuzsanna Varga et al.   LANCET

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

(2020) Maximilian Ackermann et al.   NEW ENGLAND JOURNAL OF MEDICINE

ADAMTS13 activity, von Willebrand factor, factor VIII and D-dimers in COVID-19 inpatients

(2020) R. Escher et al.   THROMBOSIS RESEARCH

Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans

(2020) Sharon E Fox et al.   Lancet Respiratory Medicine

Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis

(2020) Giuseppe Lippi et al.   CLINICA CHIMICA ACTA

Low ADAMTS 13 plasma levels are predictors of mortality in COVID-19 patients

(2020) Mario Bazzan et al.   Internal and Emergency Medicine

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

(2020) F.A. Klok et al.   THROMBOSIS RESEARCH

Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study

(2020) George Goshua et al.   Lancet Haematology

Venous Thrombosis Among Critically Ill Patients With Coronavirus Disease 2019 (COVID-19)

(2020) Julien Nahum et al.   JAMA Network Open

Hemostatic alterations in COVID-19

(2020) Flora Peyvandi et al.   HAEMATOLOGICA

ADAMTS13 activity, high VWF and FVIII levels in the pathogenesis of deep vein thrombosis

(2020) Maria Teresa Pagliari et al.   THROMBOSIS RESEARCH

Characterization and treatment of congenital thrombotic thrombocytopenic purpura

(2019) Ferras Alwan et al.   BLOOD

Reduced ADAMTS13 activity during TTP remission is associated with stroke in TTP survivors

(2019) Harshvardhan Upreti et al.   BLOOD

Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies

(2017) M. Scully et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Low ADAMTS13 activity is associated with an increased risk of ischemic stroke

(2015) M. A. H. Sonneveld et al.   BLOOD

Plasma ADAMTS-13 levels and the risk of myocardial infarction: an individual patient data meta-analysis

(2015) A. Maino et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Measurement and prevalence of circulating ADAMTS13-specific immune complexes in autoimmune thrombotic thrombocytopenic purpura

(2013) L. A. Lotta et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

von Willebrand factor propeptide to antigen ratio in acquired thrombotic thrombocytopenic purpura

(2012) F. STUFANO et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Platelet reactive conformation and multimeric pattern of von Willebrand factor in acquired thrombotic thrombocytopenic purpura during acute disease and remission

(2011) L. A. LOTTA et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Von Willebrand Factor, Type 2 Diabetes Mellitus, and Risk of Cardiovascular Disease

(2008) David S. Frankel et al.   CIRCULATION